Antisense oligonucleotide therapeutics: drug delivery and targeting

This publication has 91 references indexed in Scilit:

• Cationic Lipids Improve Antisense Oligonucleotide Uptake and Prevent Degradation in Cultured Cells and in Human Serum
  Biochemical and Biophysical Research Communications, 1993
• A spring-loaded mechanism for the conformational change of influenza hemagglutinin
  Cell, 1993
• Targeted delivery of antisense oligonucleotides by molecular conjugates
  Somatic Cell and Molecular Genetics, 1992
• Targeting of poly(rI)-poly(rC) by fusogenic (F protein) immunoliposomes
  Experimental Cell Research, 1992
• Oligonucleotides encapsulated in pH sensitive liposomes are efficient toward Friend retrovirus
  Biochemical and Biophysical Research Communications, 1992
• Phosphorothioate oligodeoxynucleotides—anti-sense inhibitors of gene expression?
  Pharmacology & Therapeutics, 1991
• Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3′‐terminus and their interaction with DNA within mammalian cells
  FEBS Letters, 1989
• Specific inhibition of lymphokine biosynthesis and autocrine growth using antisense oligonucleotides in Th1 and Th2 helper T cell clones.
  The Journal of Experimental Medicine, 1988
• Membrane Fusion by Peptide Analogues of Influenza Virus Haemagglutinin
  Journal of General Virology, 1988
• Differential metabolism of deoxyribonucleosides by leukaemic T cells of immature and mature phenotype
  British Journal of Haematology, 1985